Drugs / ASCT-83
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07363395 | Jan → Oct 2026 expected | neuropathy, painful | Alcamena Stem Cell Therapeutics | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASCT-83 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07363395 ↗ |
| Modality | Peptide | “23-amino acid, macrocyclic peptide” NCT07363395 ↗ |
| Route | Subcutaneous | “administered as two subcutaneous (SC) injections” NCT07363395 ↗ |